APA

Bartha I., Assel M., Sloot P. M. A., Zazzi M., Torti C., Schülter E., De Luca A., Sönnerborg A., Abecasis A. B., Van Laethem K., Rosi A., Svärd J., Paredes R., van de Vijver D. A. M. C., Vandamme A. & Müller V. (20140623). Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. : BMC infectious diseases.

Chicago

Bartha István, Assel Matthias, Sloot Peter M A, Zazzi Maurizio, Torti Carlo, Schülter Eugen, De Luca Andrea, Sönnerborg Anders, Abecasis Ana B, Van Laethem Kristel, Rosi Andrea, Svärd Jenny, Paredes Roger, van de Vijver David A M C, Vandamme Anne-Mieke and Müller Viktor. 20140623. Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. : BMC infectious diseases.

Harvard

Bartha I., Assel M., Sloot P. M. A., Zazzi M., Torti C., Schülter E., De Luca A., Sönnerborg A., Abecasis A. B., Van Laethem K., Rosi A., Svärd J., Paredes R., van de Vijver D. A. M. C., Vandamme A. and Müller V. (20140623). Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. : BMC infectious diseases.

MLA

Bartha István, Assel Matthias, Sloot Peter M A, Zazzi Maurizio, Torti Carlo, Schülter Eugen, De Luca Andrea, Sönnerborg Anders, Abecasis Ana B, Van Laethem Kristel, Rosi Andrea, Svärd Jenny, Paredes Roger, van de Vijver David A M C, Vandamme Anne-Mieke and Müller Viktor. Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort. : BMC infectious diseases. 20140623.